Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization.

Multiple myeloma (MM) is a hematological disorder in which the clonal growth of neoplastic plasma cells in the bone marrow is observed [1]. According to the European Hematology Association (EHA) and European Society for Medical Oncology (ESMO) recommendations, high-dose chemotherapy and autologous hematopoietic stem cell transplantation (auto-SCT) is a standard therapy for newly diagnosed patients under 70 years of age [2]. For patients at high genetic risk or receiving bortezomib, cyclophosphamide, and dexamethasone (VCD) induction, tandem transplantation is recommended [2].
Source: Experimental Hematology - Category: Hematology Authors: Tags: Article Source Type: research